After 15 Years, Life-Changing Results for this Chronic Lymphocytic Leukemia Patient
source: shutterstock.com

After 15 Years, Life-Changing Results for this Chronic Lymphocytic Leukemia Patient

Editor's Note: We believe that patients are a key part of developing and leading the conversation in disease communities. Patient Worthy sometimes partners with reputable agencies that wish to speak…

Continue Reading After 15 Years, Life-Changing Results for this Chronic Lymphocytic Leukemia Patient
A Combination of Benmelstobart, Anlotinib, and Chemotherapy Improves Survival Rates in SCLC, Study Suggests
kalhh / Pixabay

A Combination of Benmelstobart, Anlotinib, and Chemotherapy Improves Survival Rates in SCLC, Study Suggests

  Advancing patient outcomes hinges on the development of targeted treatments, particularly in conditions with grim prognoses such as small cell lung cancer (SCLC), which typically has a life expectancy…

Continue Reading A Combination of Benmelstobart, Anlotinib, and Chemotherapy Improves Survival Rates in SCLC, Study Suggests